OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer
Jeffrey J. Leow, Shagnik Ray, Shawn Dason, et al.
Urologic Clinics of North America (2023) Vol. 50, Iss. 2, pp. 285-303
Closed Access | Times Cited: 12
Jeffrey J. Leow, Shagnik Ray, Shawn Dason, et al.
Urologic Clinics of North America (2023) Vol. 50, Iss. 2, pp. 285-303
Closed Access | Times Cited: 12
Showing 12 citing articles:
Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance
Xiaolin Wu, Nuan Feng, Chao Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Xiaolin Wu, Nuan Feng, Chao Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Efficacy and safety of neoadjuvant therapy with tislelizumab plus axitinib for nonmetastatic renal cell carcinoma with inferior vena cava tumor thrombus: a retrospective study
Zhongjie Zhao, Zhengsheng Liu, Kaiyan Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Zhongjie Zhao, Zhengsheng Liu, Kaiyan Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
French AFU Cancer Committee Guidelines – Update 2024–2026: Management of kidney cancer
P. Bigot, Romain Boissier, Z. Khene, et al.
Deleted Journal (2024) Vol. 34, Iss. 12, pp. 102735-102735
Open Access | Times Cited: 2
P. Bigot, Romain Boissier, Z. Khene, et al.
Deleted Journal (2024) Vol. 34, Iss. 12, pp. 102735-102735
Open Access | Times Cited: 2
A systematic review of nanocarriers for treatment of urologic cancers
Amy Wang, Cathy Yan, Moritz Reike, et al.
Urologic Oncology Seminars and Original Investigations (2023) Vol. 42, Iss. 4, pp. 75-101
Closed Access | Times Cited: 3
Amy Wang, Cathy Yan, Moritz Reike, et al.
Urologic Oncology Seminars and Original Investigations (2023) Vol. 42, Iss. 4, pp. 75-101
Closed Access | Times Cited: 3
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
Teele Kuusk, Axel Bex
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 5, pp. 907-920
Closed Access | Times Cited: 2
Teele Kuusk, Axel Bex
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 5, pp. 907-920
Closed Access | Times Cited: 2
Comparison of aggressiveness in central versus peripheral T1a clear-cell renal cell carcinoma
S. Semko, O. Voylenko, M. Pikul, et al.
Urologic Oncology Seminars and Original Investigations (2023) Vol. 42, Iss. 2, pp. 31.e9-31.e15
Closed Access | Times Cited: 2
S. Semko, O. Voylenko, M. Pikul, et al.
Urologic Oncology Seminars and Original Investigations (2023) Vol. 42, Iss. 2, pp. 31.e9-31.e15
Closed Access | Times Cited: 2
Efficacy and safety of neoadjuvant therapy with tislelizumab plus axitinib for nonmetastatic renal cell carcinoma with inferior vena cava tumor thrombus: a retrospective study
Zhongjie Zhao, Zhengsheng Liu, Kaiyan Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Zhongjie Zhao, Zhengsheng Liu, Kaiyan Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Turning the tide: pembrolizumab’s triumph in adjuvant RCC therapy
Fouad Attieh, Marc Boutros, Hampig Raphaël Kourié, et al.
Medical Oncology (2024) Vol. 41, Iss. 10
Closed Access
Fouad Attieh, Marc Boutros, Hampig Raphaël Kourié, et al.
Medical Oncology (2024) Vol. 41, Iss. 10
Closed Access
Recommandations françaises du Comité de cancérologie de l’AFU – Actualisation 2024–2026 : cancer du rein
P. Bigot, Romain Boissier, Z. Khene, et al.
Progrès en Urologie - FMC (2024) Vol. 34, Iss. 7, pp. F333-F393
Closed Access
P. Bigot, Romain Boissier, Z. Khene, et al.
Progrès en Urologie - FMC (2024) Vol. 34, Iss. 7, pp. F333-F393
Closed Access
Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies
Adam Khorasanchi, Karan Jatwani, Lingbin Meng, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4127-4127
Open Access
Adam Khorasanchi, Karan Jatwani, Lingbin Meng, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4127-4127
Open Access
A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report
Haiyang Yang, Xiang Da Dong, Xinghe Pan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access
Haiyang Yang, Xiang Da Dong, Xinghe Pan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access
Adjuvant immunotherapy for locally advanced renal cell carcinoma
Michail Alevizakos, David F. McDermott
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 12, pp. 1265-1275
Closed Access
Michail Alevizakos, David F. McDermott
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 12, pp. 1265-1275
Closed Access
